Clinical Trial Update: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cabozantinib in combination with temozolomide for unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Soft-tissue Sarcoma
• Unresectable Leiomyosarcoma
• Unresectable Soft Tissue Sarcoma
• Uterine Leiomyosarcoma

Drugs mentioned

• Temozolomide (Temozolomide)
• cabozantinib (cabozantinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING